Accelerating the discovery and development of technologies for neglected tropical diseases, malaria, and tuberculosis by sharing intellectual property with the global health research community, catalyzing and fostering global health collaborations, and contributing to capacity-building in low- and middle-income countries.
SEE ALL PARTNER ORGANIZATIONS
- Accelerating development of new vaccines, diagnostics, and drugs for malaria, tuberculosis (TB) and Neglected Tropical Diseases (NTDs).
- To create partnerships that connect private industry’s assets and resources with qualified academic and nonprofit researchers with novel product discovery or development ideas.
- Guiding principles to ensure products are available royalty free in least developed countries.
Partnership activities and how they address needs and challenges
WIPO Re:Search, a global consortium, was founded by the World Intellectual Property Organization (WIPO) in partnership with BIO Ventures for Global Health (BVGH) and several leading pharmaceutical companies in 2011. Consortium partners recognized the need to accelerate the development of new drugs, vaccines, and diagnostics for infectious diseases. Today, WIPO Re:Search continues to advance sharing of intellectual property toward R&D for neglected tropical diseases (NTDs), malaria, and tuberculosis.
As the Partnership Hub administrator of WIPO Re:Search, BIO Ventures for Global Health (BVGH) proactively examines scientists’ current neglected disease research and proposes novel collaboration opportunities with other Members. BVGH also fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations with clearly-defined roles, responsibilities, and expectations.
The World Intellectual Property Organization (WIPO) manages the WIPO Re:Search Resource Platform, a searchable, public database of available intellectual property assets and resources. WIPO Re:Search provides access to important IP resources to support its member organizations in research on vaccines, diagnostics, and drugs for NTDs, striving ultimately to improve the lives of those most in need. WIPO Re:Search Members include prestigious academic institutions and some of the world’s leading pharmaceutical companies..
Public-Private Partnership Activities
Eisai Co., Ltd. activities: Through WIPO Re:Search, Eisai has collaborated recently with University of Yaoundé I; Infectious Disease Research Institute; and University of Buea on solutions to neglected infectious diseases including human African trypanosomiasis, leishmaniasis, malaria, onchocerciasis, and tuberculosis.
GSK activities: Through WIPO Re:Search, GSK has collaborated recently with Washington University in St. Louis; University of California, San Francisco; and Fundação Oswaldo Cruz on solutions to neglected infectious diseases including Chagas disease and malaria.
Johnson & Johnson activities: Through WIPO Re:Search, Johnson & Johnson has collaborated recently with the Walter and Eliza Hall Institute of Medical Research; Washington University in St. Louis; National Institutes of Health; and University of Yaoundé I on solutions to neglected infectious diseases including human African trypanosomiasis, leishmaniasis, malaria, and tuberculosis.
Merck KGaA, Darmstadt, Germany activities: Through WIPO Re:Search, Merck KGaA has collaborated recently with University of California, San Diego; University of Yaoundé I; and University of Buea on solutions to neglected infectious diseases including Buruli ulcer, Chagas disease, human African trypanosomiasis, leishmaniasis, and onchocerciasis. Merck KGaA is known as EMD in the US and Canada.
MSD activities: Through WIPO Re:Search, MSD has collaborated recently with Seattle Children’s Research Institute/Seattle Structural Genomics Center for Infectious Disease; The George Washington University; and Walter and Eliza Hall Institute of Medical Research on solutions to neglected infectious diseases including malaria, schistosomiasis, and tuberculosis. MSD is a trademark of Merck & Co., Inc., Kenilworth, NJ, USA.
Novartis Pharma AG activities: Novartis was a founding member of WIPO Re:Search and participated through the program’s conclusion in 2022. Over the 10 years of the program’s successful run, Novartis, among other things, collaborated with the Nigerian Institute of Medical Research; Brazilian Biosciences National Laboratory; and Public Health Research Institute on solutions to neglected infectious diseases including Chagas disease and malaria.
Pfizer Inc. activities: Through WIPO Re:Search, Pfizer has collaborated recently with Kenya Medical Research Institute; Washington University in St. Louis/The George Washington University; and Infectious Disease Research Institute on solutions to neglected infectious diseases including malaria and tuberculosis.
Takeda Pharmaceutical Company Limited activities: Through WIPO Re:Search, Takeda has collaborated recently with National Institutes of Health; Infectious Disease Research Institute; and Seattle Children’s Research Institute on solutions to neglected infectious diseases including Chagas disease, leishmaniasis, and malaria.
Elimination and eradication of malaria, tuberculosis, and neglected tropical diseases (NTDs) requires the coordinated efforts of international stakeholders from both the corporate and non-profit sectors. WIPO Re:Search is a unique and effective public-private partnership model for accelerating malaria, tuberculosis, and NTD R&D through the free sharing of IP assets.
One of the very best things that has happened to me and my institute in the recent past is being a member of WIPO Re:Search. WIPO Re:Search connects us with collaborators from developed countries. This is a feat that we have not been able to achieve for decades.
Results and milestones
Membership has grown to include over 150 organisations representing over 40 countries. Since 2011, 154 research collaborations have been established between Members. 15 of these projects progressed to the next stage of product development. In 2019, there were 54 ongoing collaborations.
Malaria, tuberculosis, Chagas disease, schistosomiasis, and soil-transmitted helminthiases are the top five most common diseases subject to WIPO Re:Search collaborations established to date.
The WIPO Re:Search Fellowship Program is building an international community of researchers to catalyze R&D for neglected diseases. Key impacts include 20 fellowships totaling 100+ months of training and securing grant funding, including over US $750,000 for one fellow.
- Global Commitment
- South-East Asia
- Infectious and Parasitic Disease
- People with low incomes
- Marginalized/indigenous people
SGDs the partnership contributes to
- 3.2: Reduce Under-5 Mortality
- 3.3: Communicable Diseases & NTDs
- 3.8: Achieve universal health coverage
Infectious Disease Research Institute (IDRI)
National Institute for Medical Research (NIMR)
University of California, San Francisco
Walter and Eliza Hall Institute of Medical Research
Public Health Research Institute
Research Institute for Tropical Medicine
Institut Pasteur Korea
National Institute of Immunology, India
University of Dundee
Walter Reed Army Institute of Research
Seattle Children's Research Institute
Theodor Bilharz Research Institute
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)
National University of Singapore
University of Edinburgh
Washington University in St Louis, USA
Social Medicine Institute - Rio de Janeiro State University
Noguchi Memorial Institute for Medical Research
International Vaccine Institute
Nigerian Institute of Medical Research
University of Florida
Ahmadu Bello University
Umaru Musa Yar’adua University
George Washington University
James Cook University
University of Georgia
Armauer Hansen Research Institute
University of Antioquia, Colombia
Kenya Medical Research Institute
Sabin Vaccine Institute
University of Ibadan
Bandung Institute of Technology
University Cheikh Anta Diop of Dakar
Centre Pasteur du Cameroon (CPC)
Kumasi Centre for Collaborative Research in Tropical Medicine
South African Medical Research Council
University of Kansas
Biomedical Center of the Central University of Ecuador
University of Bamenda
Fundação Oswaldo Cruz (FIOCRUZ)
Liverpool School of Tropical Medicine
University of Lagos
Center for Molecular Dynamics Nepal
University of Campinas
Institut Pasteur de Madagascar
Structural Genomics Consortium / University of Oxford
University of Mauritius
Center for World Health Medicine
University of Dschang
Institut Pasteur de Tunis
Addis Ababa University
University of Melbourne
Centre for Plant Medicine Research
University of Ghana
Swiss Tropical and Public Health Institute
African Institute of Biomedical Science and Technology (AiBST)
Massachusetts Institute of Technology (MIT)
University of Bamako
University of New South Wales
Congolese Foundation for Medical Research
University of Papua New Guinea - School of Medicine and Health Sciences
Biomedical Research Institute
California Institute of Technology
University of British Columbia
University of South Florida
Griffith Institute for Drug Discovery
University of São Paulo
Brazilian Biosciences National Laboratory
Case Western Reserve University
University of Buea
University of Toronto
Health Sciences Research Institute
University of South Carolina
International Centre for Genetic Engineering and Biotechnology
Council on Health Research for Development
University of Calgary
University of Vermont
Icahn School of Medicine at Mount Sinai
University of Texas
Murdoch Childrens Research Institute
University of California, Berkeley
University of Washington
Institute of Molecular and Cellular Biology of Rosario
University of Zambia
Indian Council of Medical Research
National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand
University of California, San Diego (UCSD)
University of Yaound
Medical Research Institute - Alexandria University
Usmanu Danfodiyo University, Sokoto
PATH Malaria Vaccine Initiative (MVI)
Drugs for Neglected Diseases initiative (DNDi)
Africa Fighting Malaria
Association of University Managers
International Federation of Intellectual Property Attorneys
Licensing Executive Society International
Public Interest Intellectual Property Advisors
International Hospital Federation (IHF)
Global Alliance for Livestock Veterinary Medicines (GALVmed)
US National Institutes of Health (NIH)
US Patent and Trademark Office
Massachusetts General Hospital
Texas Children's Hospital
Puerto Rico Science, Technology & Research Trust
Developing World Health
Medicines for Malaria Venture (MMV)
- WIPO Re:Search Resource Platform
- BVGH WIPO Re:Search
- Video - WIPO Re:Search - Sharing IP in the Fight Against Neglected Tropic Diseases
- News Release - Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search
- Report - Global Challenges In Focus
- Report - BVGH Partnership Hub Mid-Year Report 2019
- Report - BVGH Partnership Hub Annual Report 2018
Infectious and Parasitic Disease
- Neglected Tropical Diseases (NTDs)
- Foodborne Trematodiases
- Onchocerciasis (River Blindness)
- Soil-Transmitted Helminthiasis
- Leishmaniasis cutaneous and visceral
- Human African Trypanosomiasis (HAT)
- Buruli Ulcer
- Chagas Disease
- Dengue and Chikungunya
- Dracunculiasis (Guinea Worm)